Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleMolecular Imaging

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW

Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit and Wouter B. Nagengast
Journal of Nuclear Medicine March 2019, 60 (3) 418-423; DOI: https://doi.org/10.2967/jnumed.118.216556
Matthijs D. Linssen
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
2Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva J. ter Weele
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derk P. Allersma
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marjolijn N. Lub-de Hooge
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
3Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gooitzen M. van Dam
3Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and
4Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Annelies Jorritsma-Smit
1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wouter B. Nagengast
2Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 60 no. 3 418-423
DOI 
https://doi.org/10.2967/jnumed.118.216556
PubMed 
30630938

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 25, 2018
  • Accepted for publication September 6, 2018
  • Published online March 1, 2019.

Article Versions

  • previous version (January 10, 2019 - 13:30).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2019 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Matthijs D. Linssen1,2,
  2. Eva J. ter Weele1,
  3. Derk P. Allersma1,
  4. Marjolijn N. Lub-de Hooge1,3,
  5. Gooitzen M. van Dam3,4,
  6. Annelies Jorritsma-Smit1 and
  7. Wouter B. Nagengast2
  1. 1Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  2. 2Department of Gastroenterology and Hepatology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  3. 3Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands; and
  4. 4Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
  1. For correspondence or reprints contact: Wouter B. Nagengast, Department of Gastroenterology and Hepatology, University Medical Center Groningen, Hanzeplein 1, 9713 GZ Groningen, the Netherlands. E-mail: w.b.nagengast{at}umcg.nl
View Full Text

Statistics from Altmetric.com

Cited By...

  • 27 Citations
  • 23 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • ImmunoPET: Concept, Design, and Applications
    Weijun Wei, Zachary T. Rosenkrans, Jianjun Liu, Gang Huang, Quan-Yong Luo, Weibo Cai
    Chemical Reviews 2020 120 8
  • Fluorescence image-guided tumour surgery
    Kun Wang, Yang Du, Zeyu Zhang, Kunshan He, Zhongquan Cheng, Lin Yin, Di Dong, Changjian Li, Wei Li, Zhenhua Hu, Chong Zhang, Hui Hui, Chongwei Chi, Jie Tian
    Nature Reviews Bioengineering 2023 1 3
  • Current trends and key considerations in the clinical translation of targeted fluorescent probes for intraoperative navigation
    Renfa Liu, Yunxue Xu, Kun Xu, Zhifei Dai
    Aggregate 2021 2 3
  • EGFR-targeted fluorescence molecular imaging for intraoperative margin assessment in oral cancer patients: a phase II trial
    Jaron G. de Wit, Jasper Vonk, Floris J. Voskuil, Sebastiaan A. H. J. de Visscher, Kees-Pieter Schepman, Wouter T. R. Hooghiemstra, Matthijs D. Linssen, Sjoerd G. Elias, Gyorgy B. Halmos, Boudewijn E. C. Plaat, Jan J. Doff, Eben L. Rosenthal, Dominic Robinson, Bert van der Vegt, Wouter B. Nagengast, Gooitzen M. van Dam, Max J. H. Witjes
    Nature Communications 2023 14 1
  • Fluorescent image-guided surgery in breast cancer by intravenous application of a quenched fluorescence activity-based probe for cysteine cathepsins in a syngeneic mouse model
    Frans V. Suurs, Si-Qi Qiu, Joshua J. Yim, Carolien P. Schröder, Hetty Timmer-Bosscha, Eric S. Bensen, John T. Santini, Elisabeth G. E. de Vries, Matthew Bogyo, Gooitzen M. van Dam
    EJNMMI Research 2020 10 1
  • Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin
    Jan Marie de Gooyer, Fortuné M. K. Elekonawo, Andreas J. A. Bremers, Otto C. Boerman, Erik H. J. G. Aarntzen, Philip R. de Reuver, Iris. D. Nagtegaal, Mark Rijpkema, Johannes H. W. de Wilt
    Nature Communications 2022 13 1
  • Multispectral optoacoustic tomography for in vivo detection of lymph node metastases in oral cancer patients using an EGFR-targeted contrast agent and intrinsic tissue contrast: A proof-of-concept study
    J. Vonk, J. Kukačka, P.J. Steinkamp, J.G. de Wit, F.J. Voskuil, W.T.R. Hooghiemstra, M. Bader, D. Jüstel, V. Ntziachristos, G.M. van Dam, M.J.H. Witjes
    Photoacoustics 2022 26
  • New and effective EGFR-targeted fluorescence imaging technology for intraoperative rapid determination of lung cancer in freshly isolated tissue
    Changjian Li, Jiahui Mi, Yueqi Wang, Zeyu Zhang, Xiaoyong Guo, Jian Zhou, Zhenhua Hu, Jie Tian
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 2
  • Comparison of narrow band and fluorescence molecular imaging to improve intraoperative tumour margin assessment in oral cancer surgery
    Jaron G. de Wit, Jeroen E. van Schaik, Floris J. Voskuil, Jasper Vonk, Sebastiaan A.H.J. de Visscher, Kees-Pieter Schepman, Bernard F.A.M. van der Laan, Jan J. Doff, Bert van der Vegt, Boudewijn E.C. Plaat, Max J.H. Witjes
    Oral Oncology 2022 134
  • Improved Discrimination of Tumors with Low and Heterogeneous EGFR Expression in Fluorescence-Guided Surgery Through Paired-Agent Protocols
    Cheng Wang, Xiaochun Xu, Margaret Folaron, Jason R. Gunn, Sassan Hodge, Eunice Y. Chen, P. Jack Hoopes, Kenneth M. Tichauer, Kimberley S. Samkoe
    Molecular Imaging and Biology 2023 25 1

Article usage

Article usage: January 2019 to May 2025

AbstractFullPdf
Jan 2019402048
Feb 2019134016
Mar 20198723355
Apr 2019165710
May 201910766
Jun 20196933
Jul 20197843
Aug 201964511
Sep 2019551127
Oct 2019622833
Nov 2019481732
Dec 201932914
Jan 2020331516
Feb 2020191615
Mar 2020352423
Apr 2020272018
May 2020414423
Jun 2020162013
Jul 2020371013
Aug 2020221212
Sep 202030259
Oct 2020302215
Nov 202016147
Dec 2020172616
Jan 202153320
Feb 2021153732
Mar 2021124126
Apr 202191816
May 2021103010
Jun 2021103111
Jul 202172016
Aug 202142631
Sep 20215179
Oct 202173141
Nov 2021122836
Dec 20218236
Jan 202262017
Feb 2022112316
Mar 202251717
Apr 202282425
May 202282127
Jun 202283425
Jul 202262114
Aug 202261813
Sep 2022113127
Oct 202263620
Nov 2022143113
Dec 202233210
Jan 202383110
Feb 202332314
Mar 2023152730
Apr 202382424
May 202362015
Jun 20237159
Jul 202351419
Aug 202361415
Sep 202351913
Oct 2023103530
Nov 2023113816
Dec 202347411
Jan 2024334023
Feb 2024124421
Mar 2024101847
Apr 2024510641
May 202475222
Jun 202474520
Jul 202463121
Aug 202463230
Sep 202433512
Oct 2024104720
Nov 202464819
Dec 20244319
Jan 202534728
Feb 2025109619
Mar 202585629
Apr 202576845
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 60 (3)
Journal of Nuclear Medicine
Vol. 60, Issue 3
March 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit, Wouter B. Nagengast
Journal of Nuclear Medicine Mar 2019, 60 (3) 418-423; DOI: 10.2967/jnumed.118.216556

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW
Matthijs D. Linssen, Eva J. ter Weele, Derk P. Allersma, Marjolijn N. Lub-de Hooge, Gooitzen M. van Dam, Annelies Jorritsma-Smit, Wouter B. Nagengast
Journal of Nuclear Medicine Mar 2019, 60 (3) 418-423; DOI: 10.2967/jnumed.118.216556
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Detection of Early Esophageal Neoplastic Barrett Lesions with Quantified Fluorescence Molecular Endoscopy Using Cetuximab-800CW
  • Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer
  • Google Scholar

More in this TOC Section

Molecular Imaging

  • Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
  • Molecular Imaging of Very Late Antigen-4 in Acute Lung Injury
  • Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44
Show more Molecular Imaging

Translational

  • [99mTc]Tc-MY6349 Probe for Trop2-Targeted SPECT Imaging: From Preclinical to Pilot Clinical Study
  • Imaging Diverse Pathogenic Bacteria In Vivo with 18F-Fluoromannitol PET
  • Modeling Early Radiation DNA Damage Occurring During 177Lu-DOTATATE Radionuclide Therapy
Show more Translational

Similar Articles

Keywords

  • optical imaging
  • Roadmap
  • development
  • cGMP
SNMMI

© 2025 SNMMI

Powered by HighWire